210 related articles for article (PubMed ID: 26871895)
41. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
42. Genital anomalies in boys and the environment.
Main KM; Skakkebaek NE; Virtanen HE; Toppari J
Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):279-89. PubMed ID: 20541152
[TBL] [Abstract][Full Text] [Related]
43. Endocrine disrupting chemicals and their effects on the reproductive health in men.
Thacharodi A; Hassan S; Acharya G; Vithlani A; Hoang Le Q; Pugazhendhi A
Environ Res; 2023 Nov; 236(Pt 2):116825. PubMed ID: 37544467
[TBL] [Abstract][Full Text] [Related]
44. Germ cell cancer and disorders of spermatogenesis: an environmental connection?
Skakkebaek NE; Rajpert-De Meyts E; Jørgensen N; Carlsen E; Petersen PM; Giwercman A; Andersen AG; Jensen TK; Andersson AM; Müller J
APMIS; 1998 Jan; 106(1):3-11; discussion 12. PubMed ID: 9524557
[TBL] [Abstract][Full Text] [Related]
45. Clinical correlates of environmental endocrine disruptors.
Safe S
Trends Endocrinol Metab; 2005; 16(4):139-44. PubMed ID: 15860409
[TBL] [Abstract][Full Text] [Related]
46. Effect of endogenous and exogenous hormones on testicular cancer: the epidemiological evidence.
Giannandrea F; Paoli D; Figà-Talamanca I; Lombardo F; Lenzi A; Gandini L
Int J Dev Biol; 2013; 57(2-4):255-63. PubMed ID: 23784836
[TBL] [Abstract][Full Text] [Related]
47. Testicular dysgenesis syndrome comprises some but not all cases of hypospadias and impaired spermatogenesis.
Jørgensen N; Rajpert-De Meyts E; Main KM; Skakkebaek NE
Int J Androl; 2010 Apr; 33(2):298-303. PubMed ID: 20132348
[TBL] [Abstract][Full Text] [Related]
48. Features of impaired seminiferous tubule differentiation are associated with germ cell neoplasia in adult men surgically treated in childhood because of cryptorchidism.
Gumińska A; Slowikowska-Hilczer J; Kuzański W; Sosnowski M; Oszukowska E; Marchlewska K; Walczak-Jedrzejowska R; Niedzielski J; Kula K
Folia Histochem Cytobiol; 2007; 45 Suppl 1():S163-8. PubMed ID: 18292827
[TBL] [Abstract][Full Text] [Related]
49. Human exposure to endocrine disrupting compounds: Their role in reproductive systems, metabolic syndrome and breast cancer. A review.
Giulivo M; Lopez de Alda M; Capri E; Barceló D
Environ Res; 2016 Nov; 151():251-264. PubMed ID: 27504873
[TBL] [Abstract][Full Text] [Related]
50. Adult immunohistochemical markers fail to detect intratubular germ cell neoplasia in prepubertal boys with cryptorchidism.
Kvist K; Clasen-Linde E; Cortes D; Petersen BL; Thorup J
J Urol; 2014 Apr; 191(4):1084-9. PubMed ID: 24095908
[TBL] [Abstract][Full Text] [Related]
51. [Recent trends in male reproductive disorders].
Iwamoto T; Nozawa S
Nihon Rinsho; 2000 Dec; 58(12):2514-20. PubMed ID: 11187747
[TBL] [Abstract][Full Text] [Related]
52. Country-specific chemical signatures of persistent environmental compounds in breast milk.
Krysiak-Baltyn K; Toppari J; Skakkebaek NE; Jensen TS; Virtanen HE; Schramm KW; Shen H; Vartiainen T; Kiviranta H; Taboureau O; Brunak S; Main KM
Int J Androl; 2010 Apr; 33(2):270-8. PubMed ID: 19780864
[TBL] [Abstract][Full Text] [Related]
53. Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers.
Emerson RE; Ulbright TM
Pathology; 2010 Jun; 42(4):344-55. PubMed ID: 20438407
[TBL] [Abstract][Full Text] [Related]
54. L1-CAM is commonly expressed in testicular germ cell tumours.
Fankhauser CD; Bode PK; Hermanns T; Sander S; Beyer J; Sulser T; Altevogt P; Moch H; Tischler V
J Clin Pathol; 2016 May; 69(5):460-2. PubMed ID: 26933044
[No Abstract] [Full Text] [Related]
55. Endocrine-disrupting chemicals and male reproductive health.
Mínguez-Alarcón L; Gaskins AJ; Meeker JD; Braun JM; Chavarro JE
Fertil Steril; 2023 Dec; 120(6):1138-1149. PubMed ID: 37827483
[TBL] [Abstract][Full Text] [Related]
56. Adverse effects of endocrine disruptors on the foetal testis development: focus on the phthalates.
Habert R; Muczynski V; Lehraiki A; Lambrot R; Lécureuil C; Levacher C; Coffigny H; Pairault C; Moison D; Frydman R; Rouiller-Fabre V
Folia Histochem Cytobiol; 2009; 47(5):S67-74. PubMed ID: 20067897
[TBL] [Abstract][Full Text] [Related]
57. Testicular dysgenesis syndrome: possible role of endocrine disrupters.
Bay K; Asklund C; Skakkebaek NE; Andersson AM
Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):77-90. PubMed ID: 16522521
[TBL] [Abstract][Full Text] [Related]
58. Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations.
Skakkebaek NE; Rajpert-De Meyts E; Jørgensen N; Main KM; Leffers H; Andersson AM; Juul A; Jensen TK; Toppari J
Int J Androl; 2007 Aug; 30(4):198-204; discussion 204-5. PubMed ID: 17705804
[TBL] [Abstract][Full Text] [Related]
59. Endocrine disruptors and male reproductive function--a short review.
Chia SE
Int J Androl; 2000; 23 Suppl 2():45-6. PubMed ID: 10849494
[TBL] [Abstract][Full Text] [Related]
60. Molecular biology of testicular germ cell tumors: unique features awaiting clinical application.
Boublikova L; Buchler T; Stary J; Abrahamova J; Trka J
Crit Rev Oncol Hematol; 2014 Mar; 89(3):366-85. PubMed ID: 24182421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
